These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8555632)

  • 21. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro.
    Sperling C; Salchert K; Streller U; Werner C
    Biomaterials; 2004 Sep; 25(21):5101-13. PubMed ID: 15109834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species specificity of the anticoagulant activity of human urinary soluble thrombomodulin.
    Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Mochizuki H
    Thromb Res; 1998 Feb; 89(4):187-97. PubMed ID: 9651146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immobilization of human thrombomodulin onto PTFE.
    Sperling C; König U; Hermel G; Werner C; Müller M; Simon F; Grundke K; Jacobasch HJ; Vasilets VN; Ikada Y
    J Mater Sci Mater Med; 1997 Dec; 8(12):789-91. PubMed ID: 15348792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential co-immobilization of thrombomodulin and endothelial protein C receptor on polyurethane: activation of protein C.
    Kador KE; Mamedov TG; Schneider M; Subramanian A
    Acta Biomater; 2011 Jun; 7(6):2508-17. PubMed ID: 21414427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood coagulation: hemostasis and thrombin regulation.
    Tanaka KA; Key NS; Levy JH
    Anesth Analg; 2009 May; 108(5):1433-46. PubMed ID: 19372317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients.
    Boldt J; Schindler E; Welters I; Wittstock M; Stertmann WA; Hempelmann G
    Anaesthesia; 1995 Nov; 50(11):954-60. PubMed ID: 8678251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid.
    Chen H; Teramura Y; Iwata H
    J Control Release; 2011 Mar; 150(2):229-34. PubMed ID: 21108976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An allosteric switch controls the procoagulant and anticoagulant activities of thrombin.
    Dang OD; Vindigni A; Di Cera E
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5977-81. PubMed ID: 7597064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.
    Mohri M; Sugimoto E; Sata M; Asano T
    Thromb Haemost; 1999 Dec; 82(6):1687-93. PubMed ID: 10613656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pigs transgenic for human thrombomodulin have elevated production of activated protein C.
    Petersen B; Ramackers W; Tiede A; Lucas-Hahn A; Herrmann D; Barg-Kues B; Schuettler W; Friedrich L; Schwinzer R; Winkler M; Niemann H
    Xenotransplantation; 2009; 16(6):486-95. PubMed ID: 20042048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains.
    Nawa K; Ono M; Fujiwara H; Sugiyama N; Uchiyama T; Marumoto Y
    Biochim Biophys Acta; 1994 Apr; 1205(2):162-70. PubMed ID: 7512385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulin.
    Horie S; Ishii H; Hara H; Kazama M
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):683-91. PubMed ID: 8053894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
    Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro rheological evaluation of antithrombogenicity or anticoagulability of styrene derivative polymer.
    Lee JS; Kaibara M; Sasabe H
    Biomaterials; 1992; 13(14):1025-30. PubMed ID: 1472589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosite 2-Directed Ligands Attenuate Protein C Activation by the Thrombin-Thrombomodulin Complex.
    Chen K; Stafford AR; Wu C; Yeh CH; Kim PY; Fredenburgh JC; Weitz JI
    Biochemistry; 2017 Jun; 56(24):3119-3128. PubMed ID: 28549218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of blood coagulation by the protein C system.
    Walker FJ; Fay PJ
    FASEB J; 1992 May; 6(8):2561-7. PubMed ID: 1317308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31038480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
    Tripodi A
    Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.
    Maruyama I; Salem HH; Ishii H; Majerus PW
    J Clin Invest; 1985 Mar; 75(3):987-91. PubMed ID: 2984256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin.
    Wu QY; Sheehan JP; Tsiang M; Lentz SR; Birktoft JJ; Sadler JE
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6775-9. PubMed ID: 1650482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.